Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
30 April, 2017 01:00 IST
Aurobindo Pharma gets USFDA nod for anti-cough tablets
Source: IRIS | 21 Mar, 2017, 09.14AM
Comments  |  Post Comment

Aurobindo Pharma announced that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets, 600/30 mg and 1200/60mg (OTC). Aurobindo's Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets are the AB rated generic equivalent of Reckitt Benckiser's Mucinex DM tablets. The product will be launched in Q1FY18.

Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets helps loosen mucus and phlegm, and thin out bronchial secretions, making coughs more productive. The approved product has an estimated market size of US$ 235 million for the twelve months ending December 2016 according to IRI database.

This is the 106 th ANDA (including 21 tentative approvals) approved out of Unit VII formulation facility in Hyderabad, India used for manufacturing oral products. Aurobindo now has a total of 311 ANDA approvals (272 Final approvals including 16 from Aurolife Pharma LLC and 39 tentative approvals) from USFDA.

Shares of the company gained Rs 1.7, or 0.24%, to trade at Rs 704.90. The total volume of shares traded was 0 at the BSE (9.01 a.m., Tuesday).



Aurobindo Pharma Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Lupin receives USFDA approval for generic Benicar tablets - 28-Apr-2017 15:15
BHEL commissions 3 MW solar photovoltaic power plant - 28-Apr-2017 13:25
ICICI Bank opens new branch at Sanwer road in Indore - 28-Apr-2017 10:11
Kotak Bank to acquire entire 26% of Old Mutual's JV for Rs 12.93 bn - 28-Apr-2017 10:07
Kotak Mahindra Bank Q4 net jumps 40%; NII up 16% - 27-Apr-2017 16:39
TVS Motor Company quarterly profit falls 7% - 27-Apr-2017 16:22
Tata Motors signs contract with Defence Ministry for supply of 3,192 vehicles - 27-Apr-2017 16:18
Maruti Suzuki India quarterly earnings up 16% - 27-Apr-2017 16:08
Crude oil price of Indian basket rises marginally - 27-Apr-2017 12:27
Axis Bank falls after weak Q4 results - 27-Apr-2017 11:27
Somany Ceramics gains after starting production at unit - 27-Apr-2017 11:21
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer